DK0509036T3 - Optisk ren R(-)-albuterol til behandling af astma - Google Patents

Optisk ren R(-)-albuterol til behandling af astma

Info

Publication number
DK0509036T3
DK0509036T3 DK91902520.5T DK91902520T DK0509036T3 DK 0509036 T3 DK0509036 T3 DK 0509036T3 DK 91902520 T DK91902520 T DK 91902520T DK 0509036 T3 DK0509036 T3 DK 0509036T3
Authority
DK
Denmark
Prior art keywords
albuterol
asthma
optically pure
treatment
isomer
Prior art date
Application number
DK91902520.5T
Other languages
English (en)
Inventor
Timothy J Barberich
James W Young
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23831837&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0509036(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of DK0509036T3 publication Critical patent/DK0509036T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91902520.5T 1990-01-05 1991-01-04 Optisk ren R(-)-albuterol til behandling af astma DK0509036T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46126290A 1990-01-05 1990-01-05

Publications (1)

Publication Number Publication Date
DK0509036T3 true DK0509036T3 (da) 1996-07-29

Family

ID=23831837

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91902520.5T DK0509036T3 (da) 1990-01-05 1991-01-04 Optisk ren R(-)-albuterol til behandling af astma

Country Status (11)

Country Link
US (1) US6083993A (da)
EP (1) EP0509036B1 (da)
JP (1) JP3085705B2 (da)
AT (1) ATE135908T1 (da)
AU (1) AU7174191A (da)
CA (1) CA2073181C (da)
DE (1) DE69118359T2 (da)
DK (1) DK0509036T3 (da)
ES (1) ES2085468T3 (da)
GR (1) GR3020133T3 (da)
WO (1) WO1991009596A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
NZ500250A (en) * 1997-04-30 2001-03-30 Bridge Pharma Inc Adrenergic beta-2 agonist eutomers, feed compositions and use for increasing muscle and decreasing fat
WO1999042460A1 (en) * 1998-02-20 1999-08-26 Fine Chemicals Corporation (Proprietary) Limited Process for the production of optically enriched (r)- or (s)-albuterol
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
AU2003226603A1 (en) * 2002-04-19 2003-11-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
EP1562975A2 (en) * 2002-10-25 2005-08-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
US20050020692A1 (en) * 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
CA2545559A1 (en) * 2003-11-20 2005-06-09 Alteragon Pty Ltd. Method of decreasing fat deposits and body weight in mammals and birds
JP2008502699A (ja) * 2004-06-14 2008-01-31 セプラコール・インコーポレイテッド 肺疾患治療方法、及びそのための組成物
EP1773325A4 (en) * 2004-06-14 2007-11-07 Sepracor Inc METHODS OF USING ALBUTEROL AND AGENTS INDUCING THE OPENING OF POTASSIUM CHANNELS ACTIVATED BY CALCIUM
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
WO2012087094A1 (es) * 2010-12-21 2012-06-28 Techsphere S.A. De C.V. Composición farmacéutica inhalable para el tratamiento del asma por administración vía aérea mediante un succionador de emulación de aerosol
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1298494A (en) * 1970-06-17 1972-12-06 Allen & Hanburys Ltd Phenylethanolamine derivatives
US4965065A (en) * 1986-04-29 1990-10-23 Bristol-Myers Squibb Company Gastroprotective process and compositions
EP0320550A1 (en) * 1987-12-18 1989-06-21 Bristol-Myers Company Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
JP3085705B2 (ja) 2000-09-11
EP0509036B1 (en) 1996-03-27
ES2085468T3 (es) 1996-06-01
CA2073181C (en) 2002-04-23
AU7174191A (en) 1991-07-24
JPH05503102A (ja) 1993-05-27
CA2073181A1 (en) 1991-07-06
WO1991009596A1 (en) 1991-07-11
DE69118359T2 (de) 1996-08-14
GR3020133T3 (en) 1996-08-31
ATE135908T1 (de) 1996-04-15
US6083993A (en) 2000-07-04
DE69118359D1 (de) 1996-05-02
EP0509036A1 (en) 1992-10-21

Similar Documents

Publication Publication Date Title
DK0509036T3 (da) Optisk ren R(-)-albuterol til behandling af astma
IS4820A (is) Aðferð til meðferðar uppsölu og truflana á miðtaugakerfi sem fela í sér notkun norkisapríðs með hreina (+) ljósvirkni
YU37696A (sh) Postupak optičkog prečišćavanja jedinjenja
DE68908722D1 (de) Dampf-Phasen-Verfahren zur Herstellung eines Diamanten.
DE69030582D1 (de) Herstellung eines rekombinanten menschlichen interleukin-1-hemmers
DE69202307D1 (de) Kryogenisches Rektifikationsverfahren zur Herstellung von gereinigtem Argon.
DK0675120T3 (da) Anvendelse af ascorbyl-gamma-linolenat eller et ascorbyldihomo-gamma-linolenat til behandling af astma, cancer, kardiovaskulære og inflammatoriske lidelser
ES2138603T3 (es) Procedimiento para el aislamiento de los factores ix, x y ii altamente purificados a partir del complejo protrombinico o del plasma humano.
PT724600E (pt) Processo de preparacao de um concentrado de inter-alfa-tripsina inibidor para uso terapeutico e concentrado obtido
NO20001343D0 (no) Fremgangsmåter og sammensetninger for behandling av pulmonære forstyrrelser ved anvendelse av optisk ren (S)-salmeterol
IT1242940B (it) Impianto ad alto rendimento per la attuazione di emodialisi, emofiltrazione plasmaferesi, emodiafiltrazione
DK0402205T3 (da) Fremgangsmåde til fremstilling af oprensede albuminopløsninger
AU1438992A (en) Water extraction components produced by adhesive bonds, process for their manufacture and their use
DK1152760T3 (da) Anvendelse af 4-aminopyridin til behandling af perifere neuropatier
DE68907991D1 (de) Diamant-diamantbindung.
DK0536564T3 (da) Fremgangsmåde til fremstilling af streptolysin O, intakt streptolysin O fremstillet ved denne fremgangsmåde og dets anvendelse
BG46004A3 (en) Method for preparing optical active 2- chlor- 12- (3- dimethylamin- 2- methylpropyl)- 12h- dibenzo- (d, g) (1, 3, 6)- dioxazocini
NO985325L (no) Anvendelse av substituert azaspiran ved behandling av astma
GR74351B (da)
RU93036315A (ru) Способ лечения отрубевидного (разноцветного) лишая
BG95867A (bg) Метод за обработване на кожи,причиняващи слабо замъгляване
IT8940035A0 (it) Procedimento per la fabbricazione da lamiera in particolare di ruote,di pulegge a gole, e simili
IT8222266A0 (it) Processo per il trattamento della sindrome di difficolta'respiratoria nell'adulto.
IT218237Z2 (it) Fermaglio intercambiabile per calzature o similari applicabile nelle forature della tomaia, preferibilmente per l'allacciatura mediante stringhe.
RU2000114403A (ru) Способ лечения язвенной болезни луковицы двенадцатиперстной кишки, осложненной стенозом